Correlation Between Qualigen Therapeutics and Commercial National

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Commercial National at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Commercial National into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Commercial National Financial, you can compare the effects of market volatilities on Qualigen Therapeutics and Commercial National and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Commercial National. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Commercial National.

Diversification Opportunities for Qualigen Therapeutics and Commercial National

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Qualigen and Commercial is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Commercial National Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Commercial National and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Commercial National. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Commercial National has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Commercial National go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Commercial National

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Commercial National. In addition to that, Qualigen Therapeutics is 3.73 times more volatile than Commercial National Financial. It trades about -0.04 of its total potential returns per unit of risk. Commercial National Financial is currently generating about 0.01 per unit of volatility. If you would invest  990.00  in Commercial National Financial on August 31, 2024 and sell it today you would lose (15.00) from holding Commercial National Financial or give up 1.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy82.84%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Commercial National Financial

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Commercial National 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Commercial National Financial are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Commercial National may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Qualigen Therapeutics and Commercial National Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Commercial National

The main advantage of trading using opposite Qualigen Therapeutics and Commercial National positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Commercial National can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Commercial National will offset losses from the drop in Commercial National's long position.
The idea behind Qualigen Therapeutics and Commercial National Financial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities